efficacy and biomarker results for pembrolizumab in soft tissue and bone sarcomas
Published 7 years ago • 205 plays • Length 1:44Download video MP4
Download video MP3
Similar videos
-
1:42
efficacy of pembrolizumab in multiple subtypes of sarcoma
-
2:36
the role of biomarkers in soft tissue sarcoma treatment and research
-
2:02
predictive biomarkers of response to immunotherapy in soft tissue sarcoma
-
58:22
new immunotherapy approaches for soft tissue sarcoma
-
3:22
developing targeted therapies for soft tissue sarcomas
-
0:52
dr. burgess on pembrolizumab in sarcoma
-
20:19
biomarkers and pathology for sarcoma speaker: dr. alaa salem
-
8:14
efficacy and toxicities with trabectedin in sarcomas
-
5:01
new developments in soft tissue and bone sarcoma research
-
1:58
the convergence of targeted therapies and immuno-oncology in sarcoma
-
1:09
evaluating the activity of trabectedin and radiotherapy in sarcoma
-
1:18
dr. jonathan trent on pembrolizumab in advanced sarcomas
-
3:46
nivolumab and ipilimumab for metastatic sarcoma
-
1:49
the current landscape for sarcoma immunotherapy treatments
-
1:08
dr. movva on chemotherapy administration and survival in soft tissue sarcoma
-
7:40
promising new treatments for sarcomas: immunotherapy and fusion targeted compounds
-
5:23
olaratumab efficacy in soft-tissue sarcoma
-
1:45
pembrosarc: pembrolizumab combinations for advanced sarcoma
-
21:46
2021 west oncology app | update on sarcoma